Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

NCT06657209 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Diabetes
Type 2 Diabetes
Pre Diabetes

Interventions

PROCEDURE: Insulin resistance testing
PROCEDURE: OGTT
PROCEDURE: Fat biopsy
RADIATION: DXA scan
PROCEDURE: MRI
PROCEDURE: 1H-MRS
DRUG: Tirzepatide
DRUG: Pioglitazone

Sponsor

Stanford University